Synopsys, Inc. $SNPS Stock Sold by Impax Asset Management Group plc

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Impax Asset Management cut its Synopsys stake by 14.8% in the third quarter, selling 49,198 shares and retaining 283,731 shares worth about $123.4 million.
  • Synopsys beat quarterly estimates, reporting EPS of $3.91 versus $3.67 expected and revenue of $2.48 billion, up 42.4% year over year. The board also authorized a $1 billion share repurchase program.
  • Analysts hold a “Moderate Buy” consensus rating with an average $575 price target; meanwhile, insiders sold 117,163 shares over the past three months.
  • MarketBeat previews top five stocks to own in December.

Impax Asset Management Group plc reduced its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 14.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 283,731 shares of the semiconductor company's stock after selling 49,198 shares during the period. Synopsys comprises approximately 1.0% of Impax Asset Management Group plc's investment portfolio, making the stock its 29th largest position. Impax Asset Management Group plc owned 0.15% of Synopsys worth $123,406,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Edgestream Partners L.P. acquired a new position in shares of Synopsys in the third quarter valued at approximately $297,000. Fourier Capital Management Ltd bought a new stake in shares of Synopsys in the 3rd quarter valued at about $1,623,000. Intech Investment Management LLC grew its position in shares of Synopsys by 134.4% in the 3rd quarter. Intech Investment Management LLC now owns 25,184 shares of the semiconductor company's stock valued at $10,954,000 after buying an additional 14,438 shares during the last quarter. Silver Oak Securities Incorporated increased its stake in shares of Synopsys by 132.0% in the third quarter. Silver Oak Securities Incorporated now owns 900 shares of the semiconductor company's stock valued at $405,000 after buying an additional 512 shares during the period. Finally, Bessemer Group Inc. increased its stake in shares of Synopsys by 99.9% in the third quarter. Bessemer Group Inc. now owns 13,690 shares of the semiconductor company's stock valued at $5,954,000 after buying an additional 6,840 shares during the period. 85.47% of the stock is owned by institutional investors.

Synopsys Stock Performance

Shares of Synopsys stock opened at $435.51 on Wednesday. The business has a 50-day moving average price of $446.98 and a two-hundred day moving average price of $440.54. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company has a market cap of $83.46 billion, a P/E ratio of 76.95, a PEG ratio of 1.40 and a beta of 1.18.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the previous year, the business earned $3.39 EPS. The firm's revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys announced that its board has approved a share repurchase program on Monday, October 5th that authorizes the company to repurchase $1 billion in shares. This repurchase authorization authorizes the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Stock repurchase programs are often an indication that the company's board believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. KeyCorp raised their price objective on Synopsys from $600.00 to $605.00 and gave the stock an "overweight" rating in a research report on Thursday, October 1st. Morgan Stanley increased their target price on shares of Synopsys from $500.00 to $574.00 and gave the company an "overweight" rating in a research report on Tuesday, October 20th. Wells Fargo & Company increased their target price on shares of Synopsys from $475.00 to $540.00 and gave the company an "overweight" rating in a research report on Thursday, October 1st. Sanford C. Bernstein started coverage on shares of Synopsys in a report on Friday, September 25th. They set an "outperform" rating for the company. Finally, UBS Group set a $570.00 price target on shares of Synopsys in a research report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $575.00.

Read Our Latest Analysis on Synopsys

Insiders Place Their Bets

In other Synopsys news, insider Aart de Geus sold 24,641 shares of the business's stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares of the company's stock, valued at approximately $50,518,611.92. The trade was a 16.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the business's stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total value of $4,585,000.00. Following the completion of the transaction, the chief financial officer directly owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 117,163 shares of company stock valued at $51,366,457. Company insiders own 0.56% of the company's stock.

About Synopsys

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines